Yu Chen Jiao
Chief Tech/Sci/R&D Officer at GENETRON HOLDINGS LIMITED
Yu Chen Jiao active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENETRON HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 01/08/2017 | - |
Beijing Genetron Health Gene Technology Co., Ltd.
 Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Director/Board Member | - | - |
| Chinese Academy of Medical Sciences | Corporate Officer/Principal | 01/12/2013 | - |
Career history of Yu Chen Jiao
Training of Yu Chen Jiao
| Peking Union Medical College | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Statistics
International
| China | 4 |
| Cayman Islands | 2 |
| United States | 2 |
Operational
| Doctorate Degree | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Technology Services | 2 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Technology Services |
Genetron Holdings Ltd.
 Genetron Holdings Ltd. Medical/Nursing ServicesHealth Services Genetron Holdings, Ltd. engages in precision oncology. It provides cancer molecular profiling by using technologies in molecular biology and data science to transform cancer treatment. It products and services include diagnosis and monitoring through both LDT and IVD products. Its LDT portfolio consists of both specifically designed focused and comprehensive gene panel testing services. It also develops liver cancer early screening products. The company was founded by Si Zhen Wang, Hai Yan, and Wei Wu He in 2015 and is headquartered in Beijing, China. | Health Services |
- Stock Market
- Insiders
- Yu Chen Jiao
- Experience